Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyPatrick Cheung, Georg A. Bjarnason, Tamim Niazi et al.|European Urology|2021Cited by 128
A phase II multicenter study of stereotactic radiotherapy (SRT) for oligoprogression in metastatic renal cell cancer (mRCC) patients receiving tyrosine kinase inhibitor (TKI) therapy.Patrick Cheung, Georg A. Bjarnason, Samir Patel et al.|Journal of Clinical Oncology|2020Cited by 9
Role of liposomes in bladder cancer managementRavish J. Patel, Samir Patel, Amit A. Patel et al.|Elsevier eBooks|2026Cited by 0
Mesoporous silica nanoparticles: A novel approach in targeted leukemia therapyVidhi Pandya, Ravish J. Patel, Nidhi Trivedi et al.|Elsevier eBooks|2026Cited by 0